Regarding copy number alterations, the amplification of locus 8q24.21, where oncogene MYC and stemness factor POU5F1B reside, was similarly present in the two claudin-low groups, but more prevalent in basal ER-negative/HER2-negative cancers (Table 5). This evidence concerns the gene ESR1 and cancer.